// App-Quantinova.ai

711 : Inhibition of MAP Kinase-Interacting Kinase-1 (Mnk1) Regulates Platelet Functional Responses and Protein Synthesis in Megakaryocytes

Researchers

Presenter

  • Bhanu Kanth Manne

Principal Investigators

  • Rachit Badolia

  • Robert A. Campbell

  • Satya P. Kunapuli

  • Andrew S. Weyrich

  • Matthew T. Rondina

Medical Centers

  • Sol Sherry Thrombosis Research Center, Temple University, Philadelphia, PA

  • The Program in Molecular Medicine, University of Utah, Salt Lake City, UT

  • Molecular Medicine, Univ. of Utah, Salt Lake City, UT

  • The Program in Molecular Medicine, University of Utah, Salt Lake City, UT

  • Sol Sherry Thrombosis Research Center, Temple University, Philadelphia, PA

  • University of Utah, Salt Lake City, UT

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

Biomarkers

  • Nucleoside diphosphate kinase A

  • MAPK Interacting Serine/Threonine Kinase 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved